Adenylate cyclase and a fatty acid spin probe detect changes in plasma membrane lipid phase separations induced by dietary manipulation of the cholesterol:phospholipid ratio  by Needham, Lindsey et al.
Volume 183, number 1 FEBS 2426 April 1985 
Adenylate cyclase and a fatty acid spin probe detect changes 
in plasma membrane lipid phase separations induced by 
dietary manipulation of the cholesterol:phospholipid ratio 
Lindsey Needham+, Irene Finnegan and Miles D. Houslay* 
Institute of Biochemistry, University of Glasgow, Glasgow G12 8QQ, Scotland and ‘Department of Biochemistry, UMIST, 
PO Box 88, Manchester M&l IQD, England 
Received 8 February 1985 
Rats fed with a cholesterol supplement o their diet exhibited an increase in their plasma membrane choles- 
terol phospholipid (C/P)-lipid molar ratio from 0.72 to 0.98, whereas those fed the hypocholesterolaemic 
drug clotibrate in their diet exhibited a decrease in this ratio to 0.62. The properties of these membranes 
were analysed with regard to ligand-stimulated adenylate cyclase activity and the mobility of a fatty acid 
spin probe which allowed lipid phase separations to be identified. Membranes with elevated C/P ratios exhi- 
bited two distinct lipid phase separations, one at around 36°C that was attributed to the external half of 
the bilayer and one at around 22°C which was attributed to the inner half of the bilayer. Membranes with 
lowered C/P ratios exhibited a single lipid phase separation occurring at around 21°C which was attributed 
to the lipids of the inner half of the bilayer. These results were compared with those obtained by manipula- 
tion of C/P ratios in vitro using liposome-cholesterol exchange techniques. Dietary manipulation of the C/P 
ratio of plasma membranes in vivo led to alterations in the fold stimulation of adenylate cyclase by various 
stimulatory ligands. 
Adenylate cyclase 
1. INTRODUCTION 
Glucagon-stimulated adenylate cyclase is a 
multicomponent system consisting of at least 3 
distinct integral proteins distributed asymmetrical- 
ly in the plasma membrane. These are the receptor 
for glucagon, the guanine nucleotide regulatory 
protein N, and the catalytic unit of adenylate 
cyclase [1,2]. We have presented considerable 
evidence that changes in membrane fluidity can in- 
fluence both the activity of this enzyme and the 
degree of stimulation achieved by glucagon and 
ligands such as fluoride and guanine nucleotide 
analogues which function through N, [3]. In vitro 
studies have demonstrated that cholesterol [3-lo] 
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and specific phospholipids [3] can influence the 
functioning of this enzyme and in vivo studies [I I] 
have shown that dietary fat influences rat liver 
plasma membrane lipid composition and also leads 
to alterations in the activity of glucagon-stimulated 
adenylate cyclase. 
Cholesterol is a ubiquitous and essential consti- 
tuent of the plasma membrane of eukaryotic cells. 
Although its functional significance is unclear, it 
has the ability to alter bilayer fluidity, suppress 
non-specific leakage of polar substances across 
membranes and to create discrete domains in the 
bilayer by virtue of its interaction with specific 
phospholipid species (see [3,5,12]). Manipulation 
of the cholesterol content of rat liver plasma mem- 
brane in vitro using liposome-cholesterol exchange 
techniques leads to pronounced changes in the 
physical properties of the membrane and in 
adenylate cyclase activity [4,5]. Here we use 
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dietary manipulations to show that functionally 
significant changes in the cholesterol : phos- 
pholipid molar ratio of rat liver plasma mem- 
branes can be achieved in vivo. In this study a 
cholesterol supplement to the diet was used to 
elevate plasma membrane cholesterol concentra- 
tions and the drug clofibrate, which is an effective 
hypolipidemic and hypocholesterolemic agent in 
both man and rat [ 13,141, to decrease plasma 
membrane cholesterol concentrations. 
2. MATERIALS AND METHODS 
Adenylate cyclase was assayed as described [151; 
incubations were performed at 30°C unless stated 
otherwise with initial rates taken from linear time 
courses under all conditions. Stimulating ligands 
were used at concentrations that were saturating 
under all conditions and these are specified in the 
legends [ 151. 
Total lipids were extracted from liver plasma 
membranes using the method of Johnson [16]. 
Phospholipid phosphorus was determined by the 
method of Petitou et al. [17] by using the 
mineralisation procedure of Morrison [18]. 
Cholesterol was determined colourimetrically us- 
ing a horseradish peroxidase assay as detailed by us 
t41. 
Liver plasma membranes were prepared from 
male Sprague-Dawley rats as described by us [ 191. 
Twelve week old rats were allowed to feed and 
drink ad libitum, for a 4 week period prior to kill- 
ing. Control rats were given the standard 
laboratory food which we have used in all of our 
previous studies (review [3]); this was Rat Breeding 
Diet (Oxoid 41B) from Pilsbury, Birmingham, 
England. The ‘high’ cholesterol animals had a 
10% (w/w) supplement of cholesterol in their food 
and ‘low’ cholesterol animals had a 0.01% (w/w) 
supplement of clofibrate (ethyl 2-p-chlorophen- 
oxyisobutyrate) in their food [ 13,141. 5 ’ -Nucleo- 
tidase, glucose-6-phosphatase and succinate dehy- 
drogenase were assayed as in [19]. 
ESR procedures were performed as described by 
us [20-231. Briefly the N-oxyl 4’,4’-dimethyloxa- 
zolidine derivative of 5-ketostearic acid, 1(3,12) 
was used as a spin probe at experimentally deter- 
mined ‘low probe’ concentrations (9 pg/mg mem- 
brane protein). The outer and inner hyperfine 
splittings, 2T,, and 2T, were used to calculate the 
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polarity corrected order parameter S. Arrhenius 
plots were constructed using S, which has been 
shown to be a useful parameter for following 
changes in fluidity in these membranes [20,21]. A 
Varian E9 EPR spectrometer was used on 2.0 G 
modulation amplitude, 0.30 s time constant, < 5 x 
lo3 receiver gain, 10 mW microwave power, 
9.24 GHz microwave frequency all set on a scan 
range of 100 G run on a scan time of 4 min. 
Clofibrate (Atromid S) was a gift from ICI 
Pharmaceuticals, Cheshire, England. Creatine 
kinase, ATP, GTP guanine nucleotide analogues, 
cyclic AMP and horseradish peroxidase were from 
Boehringer (England). Phosphocreatine and 
cholesterol were from Sigma (England). Benzyl 
alcohol and Norit GS charcoal were from Hopkin 
and Williams, Essex. Glucagon was a gift from Dr 
W.W. Bromer, Eli Lilly, IN, USA. [3H]cyclic 
AMP was from Amersham International, Amer- 
sham, England. The spin probe 1(12,3) was ob- 
tained from Syva, Palo Alto, CA. 
3. RESULTS 
The cholesterol/phospholipid molar ratio of the 
liver plasma membranes from animals fed on the 
standard diet was 0.72 + 0.06, on the cholesterol- 
supplemented diet, 0.98 + 0.03 and on the 
clofibrate-treated diet, 0.62 + 0.02 (SE, n = 6 
animals). The plasma membrane fractions 
recovered in all cases contained over 70% of the 
total adenylate cyclase and 5 ’ -nucleotidase ac- 
tivities and were separated from endoplasmic 
reticulum and mitochondria as indicated by the 
fact that they contained less than 1% of the total 
glucose-6-phosphatase and succinate dehydro- 
genase activities. 
Dietary manipulation of cholesterol concentra- 
tions clearly gives rise to a marked change in the 
fold activation of liver plasma membrane 
adenylate cyclase to stimulatory ligands (table 1). 
An enhanced stimulatory effect was seen with the 
high cholesterol membranes and a decreased effect 
with the low cholesterol membranes from 
clofibrate-treated animals. This contrasts with ex- 
periments [4,5] where the cholesterol content of 
the isolated plasma membranes was manipulated 
in vitro. Under such conditions little alteration in 
the fold activation, elicited by either fluoride or 
glucagon, was apparent (table 1). 
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Table 1 
Fold stimulation of plasma membrane adenylate cyclase by various ligands 
Stimulating Control High cholesterol Low cholesterol 
ligand membranes membranes membranes 
PWHIPPG x12* 2 x17* 4 x 6?2 
NaF x16& 2 x55 f 11 x 4+1 
(x 14 * 3)a (x 15 5 3)” (x 16 + 3)a 
Forskolin x20+3 x33+ 4 x10*2 
Glucagon x18+3 X45& 7 x 622 
( x 22 * 2)” (x 16 + 2)” (x20 * 3)a 
Glucagon + GTP x37 f 6 x90 Y!Z 15 x 9*2 
a Data adapted from [4,5] where cholesterol manipulations of comparable 
magnitude were achieved in vitro using isolated plasma membranes with no 
changes in other membrane lipid components occurring 
All assays were performed at 30°C. The specific activities of basal adenylate 
cyclase were 12.8 + 2.0 pmol/min per mg protein (control membranes, C/P = 
0.72), 2.7 + 0.5 pmol/min per mg protein (high cholesterol membranes, C/P = 
0.98) and 39.4 + 3.0 pmol/min per mg protein (low cholesterol membranes, 
C/P = 0.62) (n = 6 animals, SE). Fold activation is based upon the net increase 
in activity over the corresponding basal activity. Concentrations of stimulatory 
ligands were NaF (15 mM), p[NH]ppG (1 mM), glucagon (1 ,uM) and glucagon 
(1 PM) + GTP (10pM). p[NH]ppG, guanosine 5’-v,y-imidoltriphosphate 
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Fig. 1. Arrhenius plots of adenylate cyclase activity in rat 
liver plasma membranes with dietary altered cholesterol 
content. Plots of adenylate cyclase activity (log v) in 
pmol/min per mg protein vs l/T (K), for high 
cholesterol membranes (a,b,c) and low cholesterol 
membranes (d,e,f). Stimulating ligands were 15 mM 
NaF (a,d), 10m6 M glucagon + 50 mM benzyl alcohol 
5 325 335 3.45 355 l2 (b,e) and 10m6 M glucagon alone (c,f). 
In the presence of 50 mM benzyl alcohol the 
glucagon stimulated activity was increased some 
1.7 + 0.2 fold for control membranes, 1.7 f 0.3 
fold for high cholesterol membranes and 1.6 + 0.2 
fold for low cholesterol membranes. The fluoride- 
stimulated activity was increased some 2.4 f 0.3 
fold for control membranes, 2.4 & 0.5 fold for 
high cholesterol membranes and 2.1 + 0.4 fold for 
low cholesterol membranes. 
Arrhenius plots of both fluoride- and glucagon- 
stimulated adenylate cyclase activity from high 
cholesterol membranes were non-linear (fig. 1). 
The glucagon-stimulated activity showed two 
distinct breaks at 36 f 3 and 22 f 2°C whereas the 
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fluoride-stimulated activity showed a single one at 
21 + 2°C. The presence of 50 mM benzyl alcohol 
caused the temperature at which the breaks oc- 
curred in the Arrhenius plot of the glucagon- 
stimulated adenylate cyclase activity to be de- 
pressed by some 10°C occurring now at 26 + 2 
and 11 f 2°C (fig.1). In low cholesterol mem- 
branes a single break at 21 + 2°C occurred in 
Arrhenius plots of the glucagon-stimulated activi- 
ty. This was decreased by some 9”C, to 12 + 3°C 
when assays were performed in the presence of 
50 mM benzyl alcohol. The Arrhenius plot of the 
fluoride-stimulated activity was linear (fig.2) (SE, 
n = 6 animals). 
In ESR experiments using the 1(12,3) spin probe, 
then, in high cholesterol membranes, lipid phase 
separations occurring at both 34 zf: 2 and 22 + 3°C 
were evident from Arrhenius-type plots of the 
polarity corrected order parameter, S. In contrast, 
there was evidence for but a single lipid phase 
separation occurring at 20 +_ 3°C in low cholesterol 
membranes (fig.2) (SE, n = 6 animals). 
45’ ’ ’ 
34 32 33 34 35 36 
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Fig.2. Identification of lipid phase separations occurring 
in rat liver plasma membranes with dietary manipulated 
cholesterol content. High cholesterol (a) and low 
cholesterol (b) liver plasma membranes were loaded with 
experimentally determined [20,21] ‘low probe’ 
concentrations of the spin label 1(12,3). This shows 
Arrhenius plots of the polarity corrected order 
parameter S vs l/T (K). 
4. DISCUSSION 
A number of independent physical techniques 
used by various workers have demonstrated that a 
lipid phase separation occurs at around 28°C in rat 
liver plasma membranes (see [3]). A number of 
criteria have been used to localise this lipid phase 
separation to the lipids in the external half of the 
plasma membrane bilayer (see [3]). Thus the activi- 
ty of adenylate cyclase, when stimulated through 
the guanine nucleotide regulatory protein N, is 
controlled solely by the lipids of the inner half of 
the bilayer where these components reside (3,221. 
Arrhenius plots of NaF-stimulated adenylate 
cyclase activity thus monitor the inner half of the 
bilayer and are linear in rat liver plasma mem- 
branes [3,5,24]. In contrast, when stimulated by 
glucagon, a transmembrane complex forms be- 
tween the glucagon receptor and these units whose 
activity is modulated by lipids of both halves of the 
bilayer [25]. Thus the Arrhenius plots of the 
glucagon-stimulated activity of rat liver plasma 
membranes exhibit a well-defined break at around 
28°C [5,15,24]. The forms of the Arrhenius plots 
of these two ligand-stimulated states of adenylate 
cyclase have thus provided useful tools for dissec- 
ting out asymmetric changes in the liver plasma 
membrane [3]. 
Here we see that high cholesterol feeding 
elevated plasma membrane cholesterol whereas 
treatment with the hypocholesterolaemic drug 
clofibrate, decreased plasma membrane choleste- 
rol. Such actions led to dramatic changes in the 
forms of the Arrhenius plots of adenylate cyclase 
activity in liver plasma membrane (fig.1). These 
are lipid-mediated effects, due to lipid phase 
separations, as corresponding effects were ob- 
served with a fatty acid spin probe inserted into the 
plasma membranes (fig.2). Also, benzyl alcohol, 
which increases membrane fluidity [3,20], activates 
adenylate cyclase [3,20] and decreases the onset of 
lipid phase transitions/separations [20], elicits an 
appropriate depression in the temperature at which 
break points occurred in the Arrhenius plots. 
In high cholesterol membranes, Arrhenius plots 
of both the order parameter S (fig.2) and 
glucagon-stimulated adenylate cyclase (fig. 1) ex- 
hibited two distinct breaks at around 36 and 22°C. 
However, Arrhenius plots of the fluoride- 
stimulated activity, which were linear using control 
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membranes, now exhibited a single break at 
around 22°C (fig.1). This suggests that the break 
occurring at around 36°C is located in the external 
half of the bilayer and that at around 22°C can be 
attributed to the lipids of the inner/cytosol half of 
the bilayer. 
In low cholesterol membranes, Arrhenius plots 
of both the order parameter S (fig.2) and 
glucagon-stimulated activity (fig. 1) exhibited a 
single break at around 21 “C. As Arrhenius plots of 
the fluoride-stimulated activity were linear then the 
lipid phase separation occurring at around 21°C 
may be attributed to the lipids of the external half 
of the bilayer. 
It is of interest to compare these results with 
those obtained from liver plasma membranes 
whose cholesterol content was manipulated to a 
comparable extent in vitro using liposome- 
cholesterol exchange techniques [4,5]. Comparable 
high cholesterol concentrations both in vitro [26] 
and in vivo led to the temperature at which the 
lipid phase separation occurred in the outer half of 
the bilayer to be increased from around 28 to 
around 36°C. However, in vivo manipulation led 
to a new lipid phase separation occurring in the in- 
ner half of the bilayer. Cholesterol depletion by 
comparable amounts both in vivo and in vitro by 
either liposome-cholesterol exchange [5] or by the 
polyene antibiotic amphotericin B [27] led to the 
temperature at which the lipid phase separation oc- 
curred in the outer half of the bilayer to be de- 
creased from around 28 to around 22°C. However, 
in vitro a new lipid phase separation occurring at 
around 13°C was apparent [5]. Thus both in vitro 
and in vivo manipulations of the cholesterol: 
phospholipid ratio lead to very similar effects on 
the lipid phase separation occurring in the outer 
half of the bilayer. This is not true, however, for 
the inner half of the bilayer where distinctly dif- 
ferent effects are exerted for comparable changes 
in the cholesterol : phospholipid molar ratio. The 
explanation for this is, however, undoubtedly due 
to the fact that both high cholesterol and clofibrate 
treatments have been shown to trigger changes in 
membrane phospholipid content in rat liver 
[28-301 and other tissues [31-331. In the case of 
clofibrate, part of this effect may be due to its 
ability to perturb fatty acid metabolism [26,27]. 
However, in both instances changes in membrane 
cholesterol content might be expected to trigger the 
adaptive or homeoviscous mechanism present in 
mammalian and other cells (see 112,341). This at- 
tempts to normalise the physical properties of 
membranes under a particular set of environmen- 
tal conditions. Indeed, we see here that in vivo, 
despite a dramatic manipulation of membrane 
cholesterol content, the ability of benzyl alcohol to 
activate adenylate cyclase was unchanged, sug- 
gesting that the fluidity of the environment of this 
enzyme was similar in all cases. In contrast, altera- 
tion of cholesterol content in vitro led to marked 
differences in sensitivity of the enzyme to activa- 
tion by benzyl alcohol [4,5]. A further indication 
that the membrane phospholipid environment of 
the enzyme might be altered during the in vivo 
dietary manipulations comes from our observa- 
tions of the sensitivity of adenylate cyclase to 
stimulation by various ligands (table 1) where 
cholesterol-depletion reduced stimulation, whereas 
high cholesterol enhanced stimulation. This does 
not appear to be a direct action of cholesterol as its 
manipulation in vitro [4,5] did not lead to these 
profound changes (table 1). The precise reasons 
for these changes in response in vivo, be they lipid 
or protein-mediated, remain to be determined. 
Clearly, such alterations in the functioning of a 
key regulatory enzyme might contribute part of the 
explanation for the widespread metabolic and 
other changes that occur in hepatic tissues where 
cholesterol :phospholipid ratios are perturbed by 
diet, drugs or disease (see [12,34-361). 
Our study clearly shows that dietary manipula- 
tion of the cholesterol:phospholipid ratio in rat 
liver plasma membranes can lead to alterations in 
lipid phase separations and the functioning of an 
integral membrane protein, adenylate cyclase. The 
changes in lipid phase separations indicate that 
liver cells have the ability to elicit asymmetric 
changes in the lipid bilayer. This is consistent with 
asymmetric changes in the lipid phase separations 
that are triggered in hamster liver plasma mem- 
branes during hibernation [37]. 
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